Join
Live feed
·
INSIDERFilingvia Quantisnow
Ensysce Biosciences Inc. logo

SEC Form 4: Kirkpatrick Lynn bought $48,298 worth of shares (97,000 units at $0.50), increasing direct ownership by 34% to 381,851 units

ByQuantisnow·Wall Street's wire, on your screen.
ENSC· Ensysce Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ENSC (Ensysce Biosciences Inc.) and more on Quantisnow.